Coca-Cola Europacific Partners is the world's largest independent Coca-Cola bottler by revenue, spanning developed European markets alongside the fast-growing Australia, Pacific, and Southeast Asia (APS) region. Its quarterly updates are closely watched because they offer a real-time read on consumer demand for beverages, the effectiveness of pricing strategy, and the health of categories such as zero sugar, energy, and hydration. The Q3 2026 trading update matters because it arrives amid persistent cost inflation, a value-conscious consumer, and geopolitical uncertainty that has pushed operating expenses higher. With management reaffirming full-year guidance, I’m watching this closely to see whether volume and pricing momentum can be sustained into a fourth quarter that carries six fewer trading days than the prior year.
CCEP publishes revenue and volume figures for its first and third quarters as a trading update, reserving full earnings-per-share (EPS) disclosures for its half-year and full-year results. For the third quarter of 2026, the company reported revenue of €5.76 billion, an increase of 6.5% on a reported basis and 5.8% on a comparable, FX-neutral basis. This was supported by volume growth of 3.6% in unit cases and a 2.2% increase in revenue per unit case, reflecting promotional optimization, positive brand and pack mix, and headline pricing. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Nine-month revenue reached €16.49 billion, up 5.1% on a reported basis. By geography, Europe grew 5.8% on an FX-neutral basis, while the APS segment advanced more quickly in the quarter. On the category side, energy volumes climbed 17.3%, sports grew 10.8%, and water rose 10.8%, while Coke Zero Sugar delivered 9.7% growth. Full-year 2026 guidance was reaffirmed, including comparable revenue growth of 3% to 4%, approximately 7% operating profit growth, capital expenditure of about 5% of revenue, and comparable free cash flow of at least €1.7 billion.
CCEP's shares have historically responded to quarterly updates based less on any single revenue figure and more on the direction of full-year guidance and dividend signals. The Q3 2026 update was broadly viewed as constructive, with volume growth balanced across home and away-from-home (AFH) channels and across both Europe and APS. The reaffirmation of guidance — alongside a second-half interim dividend of €1.42 per share and continued progress on the €1 billion buyback — supported the view that the company is managing cost headwinds without sacrificing growth investment. The main areas of investor focus were the higher operating-cost environment, particularly in commodities and operating expenses, and the six fewer trading days in the fourth quarter, both of which management has said are already reflected in unchanged full-year guidance.
Looking ahead, the fourth quarter will be a critical test of whether CCEP's momentum carries through a period with six fewer consumption days and a still-inflationary cost backdrop. Management noted that October trading returned to normal after some softness in Germany during the quarter, and that pricing decisions are largely in place heading into 2027.
Investors should monitor several factors. First, commodity and operating-expense inflation will determine how much pressure hedges and productivity savings can offset. Second, the company's revenue and margin growth management (RMGM) capabilities will be key to balancing affordability and premiumization as value-conscious consumers trade between pack formats. From what I see, the APS region remains a long-term growth engine, with strong double-digit volume growth in Indonesia and steady momentum in the Philippines. Finally, shareholder returns will stay in focus, with the full-year dividend of €2.24 per share and the conclusion of the €1 billion buyback this year. Management has signaled confidence heading into 2027, but the consumer environment and geopolitical cost pressures remain the key variables to watch.
In my day-to-day analysis, I find Tickeron’s AI Screener particularly useful for quickly scanning beverage and consumer staples names. It lets me apply filters for technical patterns, fundamentals, and performance metrics so I can compare CCEP against peers without spending hours on manual work. This kind of tool helps surface context around earnings-driven moves and keeps my process efficient when markets are moving fast.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The 10-day moving average for CCEP crossed bullishly above the 50-day moving average on October 16, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 75%.
The Momentum Indicator moved above the 0 level on October 07, 2026. You may want to consider a long position or call options on CCEP as a result. In 62 of 98 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 63%.
The Moving Average Convergence Divergence (MACD) for CCEP just turned positive on September 29, 2026. Looking at past instances where CCEP's MACD turned positive, the stock continued to rise in 23 of 47 cases over the following month. The odds of a continued upward trend are 49%.
CCEP moved above its 50-day moving average on October 12, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +4.18% 3-day Advance, the price is estimated to grow further. Considering data from situations where CCEP advanced for three days, in 190 of 352 cases, the price rose further within the following month. The odds of a continued upward trend are 54%.
The Aroon Indicator entered an Uptrend today. In 162 of 282 cases where CCEP Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 57%.
The 10-day RSI Indicator for CCEP moved out of overbought territory on October 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 36 similar instances where the indicator moved out of overbought territory. In 8 of the 36 cases, the stock moved lower in the following days. This puts the odds of a move lower at 22%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 32 of 71 cases where CCEP's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 45%.
CCEP broke above its upper Bollinger Band on October 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Profit vs. Risk Rating rating for this company is 8 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 71, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 26 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 41 (best 1 - 100 worst), indicating steady price growth. CCEP’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 76 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.145) is normal, around the industry mean (-4.128). P/E Ratio (26.032) is within average values for comparable stocks, (25.797). Projected Growth (PEG Ratio) (2.715) is also within normal values, averaging (3.732). Dividend Yield (0.033) settles around the average of (0.039) among similar stocks. P/S Ratio (1.873) is also within normal values, averaging (2.785).
The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a bottling company with interests in marketing, production and distribution of Coca-Cola products
Industry BeveragesNonAlcoholic